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BACKGROUND:
Our lab is interested in Parkinson’s Disease. One
hallmark of PD is the accumulation of toxic protein
aggregates made up of alpha-synuclein known as Lewy
Bodies. It is believed that these protein aggregates are
cleared from the cell via autophagy, a cellular process in
which proteins, organelles, other cellular debris are
engulfed in a vesicle (autophagosome) and degraded
following fusion with a lysosome (Morrison). Despite
many advances being made in the study of autophagy
and PD, The PD community has yet to find any disease
modifying treatments. With this in mind, we have
decided to shift our focus towards lipid signaling, a
topic that has not yet been adequately addressed. We
recently performed an unbiased lipidomic screen of
factors that affect autophagy and identified Stearic
Acid, Hydroxystearic acid, and 5-OXO-ETE as autophagy
inhibitors. After validation of these lipids, we set out to
test the ability of an autophagy inducing drug, Torin 1
to rescue the autophagy inhibition associated with
treatment of these lipids.

METHODS:
Cell culture
• Treat SH-SY5Y cells with Retinoic acid for 7 days.
• Treat cells with 2 different doses of fresh Torin 1
(250nM or 1 uM) or HBSS (positive control) with
and without Bafilomycin A1 in media prepared
with freshly thawed 15% FBS for 4 hours.
• Lyse and sonicate cells and then perform western
blot.
Western blot
• Run samples on a 16% Tris glycine gel for 90
minutes at 130 volts.
• Transfer samples via iBlot2 machine for 20
minutes at 10 volts.
• Membrane was probed for LC3-II and B-actin.

Torin 1 Restores Autophagy
Through Lipid-Screening Inhibition

• Our initial hypothesis was unsuccessful
because it did not yield reliable results, so we
believe that the dose may either not have
been appropriate or the solution was too old
to use.
• Our second attempt was much more reliable
and successful as we can see in lane 6, it looks
thicker than lane 2. This can be seen by the
strength/intensity and darkness of the band
(6). This means that Torin at 1uM worked.

DISCUSSION AND FUTURE DIRECTIONS:
• This is still a work in progress. We will
conduct our Torin rescue experiment next.
• With our next Torin experiment, we expect
that when we treat with lipids, we will see a
decrease in autophagy compared to ethanol
control. When we treat with lipids and Torin,
we should see autophagy go back to normal
or close to the control.
• We seemed to have successfully identified the
problem with our initial experiment. We will
repeat the planned experiment with a dosage
of 1uM (see below)

• Due to extenuating circumstances, our
research program has been postponed and
we’ll perform the above experiment as soon
as we are able to.
• Our results will add to our understanding of
the molecular mechanism of action for these
3 autophagy-repressing lipids which could
ultimately aid in the development of
treatments for neurodegenerative diseases.
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